Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Foley, 2011, Endocytosis, recycling, and regulated exocytosis of glucose transporter 4, Biochemistry, 50, 3048, 10.1021/bi2000356 Ho, 2011, A critically swift response: insulin-stimulated potassium and glucose transport in skeletal muscle, Clin J Am Soc Nephrol, 6, 1513, 10.2215/CJN.04540511 Peterson, 1977, Effect of sodium intake on renal potassium excretion, Am J Physiol, 233, F225 Meneton, 2004, Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule, Am J Physiol Renal Physiol, 287, F593, 10.1152/ajprenal.00454.2003 Sansom, 2007, Two channels for one job, Kidney Int, 72, 529, 10.1038/sj.ki.5002438 Palmer BF, Clegg DJ. Physiology and pathophysiology of potassium homeostasis: core curriculum 2019. Am J Kidney Dis. 2019;74:682–695. Rossier, 2015, Epithelial sodium transport and its control by aldosterone: the story of our internal environment revisited, Physiol Rev, 95, 297, 10.1152/physrev.00011.2014 Giebisch, 2010, Potassium transport—an update, J Nephrol, 23, S97 Young, 1985, Analysis of long-term potassium regulation, Endocr Rev, 6, 24, 10.1210/edrv-6-1-24 Pearce, 2007, Salt, sodium channels, and SGK1, J Clin Invest, 117, 592, 10.1172/JCI31538 Gumz, 2015, An integrated view of potassium homeostasis, N Engl J Med, 373, 60, 10.1056/NEJMra1313341 Castaneda-Bueno, 2012, Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process, Proc Natl Acad Sci U S A, 109, 7929, 10.1073/pnas.1200947109 Gumz, 2013, Role of circadian rhythms in potassium homeostasis, Semin Nephrol, 33, 229, 10.1016/j.semnephrol.2013.04.003 Gumz, 2009, The circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice, J Clin Invest, 119, 2423, 10.1172/JCI36908 Salhi, 2012, Circadian expression of H,K-ATPase type 2 contributes to the stability of plasma K(+) levels, FASEB J, 26, 2859, 10.1096/fj.11-199711 Zuber, 2009, Molecular clock is involved in predictive circadian adjustment of renal function, Proc Natl Acad Sci U S A, 106, 16523, 10.1073/pnas.0904890106 Chen, 1994, Influence of gender on renal thiazide diuretic receptor density and response, J Am Soc Nephrol, 5, 1112, 10.1681/ASN.V541112 Rojas-Vega, 2015, Ovarian hormones and prolactin increase renal NaCl cotransporter phosphorylation, Am J Physiol Renal Physiol, 308, F799, 10.1152/ajprenal.00447.2014 Veiras, 2017, Sexual dimorphic pattern of renal transporters and electrolyte homeostasis, J Am Soc Nephrol, 28, 3504, 10.1681/ASN.2017030295 Hayes, 1967, An extravenal mechanism for the maintenance of potassium balance in severe chronic renal failure, Trans Assoc Am Physicians, 80, 207 Hayes, 1965, Fecal potassium excretion in patients on chronic intermittent hemodialysis, Trans Am Soc Artif Intern Organs, 11, 242, 10.1097/00002480-196504000-00046 Knoll, 2002, Renin-angiotensin system blockade and the risk of hyperkalemia in chronic hemodialysis patients, Am J Med, 112, 110, 10.1016/S0002-9343(01)01068-3 Martin, 1986, Increased secretion of potassium in the rectum of humans with chronic renal failure, Am J Kidney Dis, 8, 105, 10.1016/S0272-6386(86)80120-2 Movilli, 2018, Use of renin-angiotensin system blockers increases serum potassium in anuric hemodialysis patients, Am J Nephrol, 48, 79, 10.1159/000491552 Sandle, 1986, Enhanced rectal potassium secretion in chronic renal insufficiency: evidence for large intestinal potassium adaptation in man, Clin Sci (Lond), 71, 393, 10.1042/cs0710393 Sausbier, 2006, Distal colonic K(+) secretion occurs via BK channels, J Am Soc Nephrol, 17, 1275, 10.1681/ASN.2005101111 Sorensen, 2010, Colonic potassium handling, Pflugers Arch, 459, 645, 10.1007/s00424-009-0781-9 Sorensen, 2010, Adrenaline-induced colonic K+ secretion is mediated by KCa1.1 (BK) channels, J Physiol, 588, 1763, 10.1113/jphysiol.2009.181933 Blanchard, 2017, Gitelman syndrome: consensus and guidance from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference, Kidney Int, 91, 24, 10.1016/j.kint.2016.09.046 Lalioti, 2006, Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule, Nat Genet, 38, 1124, 10.1038/ng1877 Yang, 2007, Molecular pathogenesis of pseudohypoaldosteronism type II: generation and analysis of a Wnk4(D561A/+) knockin mouse model, Cell Metab, 5, 331, 10.1016/j.cmet.2007.03.009 Terker, 2015, Potassium modulates electrolyte balance and blood pressure through effects on distal cell voltage and chloride, Cell Metab, 21, 39, 10.1016/j.cmet.2014.12.006 Bollag, 2014, Regulation of aldosterone synthesis and secretion, Compr Physiol, 4, 1017, 10.1002/cphy.c130037 Arroyo, 2011, Aldosterone paradox: differential regulation of ion transport in distal nephron, Physiology (Bethesda), 26, 115 Weinstein, 2012, Potassium excretion during antinatriuresis: perspective from a distal nephron model, Am J Physiol Renal Physiol, 302, F658, 10.1152/ajprenal.00528.2011 Shibata, 2013, Mineralocorticoid receptor phosphorylation regulates ligand binding and renal response to volume depletion and hyperkalemia, Cell Metab, 18, 660, 10.1016/j.cmet.2013.10.005 Greenlee, 2011, Mineralocorticoids stimulate the activity and expression of renal H+,K+-ATPases, J Am Soc Nephrol, 22, 49, 10.1681/ASN.2010030311 Wilcox, 1984, Factors affecting potassium balance during frusemide administration, Clin Sci (Lond), 67, 195, 10.1042/cs0670195 2000, Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group, JAMA, 283, 1967, 10.1001/jama.283.15.1967 Palmer, 2015, Hyperkalemia, JAMA, 314, 2405, 10.1001/jama.2015.9230 Foley, 2008, Creatinine-based glomerular filtration rates and microalbuminuria for detecting metabolic abnormalities in US adults: the National Health and Nutrition Examination Survey 2003-2004, Am J Nephrol, 28, 431, 10.1159/000112808 Drawz, 2012, Metabolic complications in elderly adults with chronic kidney disease, J Am Geriatr Soc, 60, 310, 10.1111/j.1532-5415.2011.03818.x Pecoits-Filho, 2019, Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care, J Clin Hypertens (Greenwich), 21, 991, 10.1111/jch.13563 Palmer, 2010, A physiologic-based approach to the evaluation of a patient with hypokalemia, Am J Kidney Dis, 56, 1184, 10.1053/j.ajkd.2010.07.010 van Ypersele de Strihou, 1977, Potassium homeostasis in renal failure, Kidney Int, 11, 491, 10.1038/ki.1977.66 Stanton, 1989, Renal potassium transport: morphological and functional adaptations, Am J Physiol, 257, R989 Vehaskari, 1989, Increased sodium transport by cortical collecting tubules from remnant kidneys, Kidney Int, 36, 89, 10.1038/ki.1989.165 Schultze, 1971, On the adaptation in potassium excretion associated with nephron reduction in the dog, J Clin Invest, 50, 1061, 10.1172/JCI106577 Bourgoignie, 1981, Renal handling of potassium in dogs with chronic renal insufficiency, Kidney Int, 20, 482, 10.1038/ki.1981.165 Frindt, 2015, Acute effects of aldosterone on the epithelial Na channel in rat kidney, Am J Physiol Renal Physiol, 308, F572, 10.1152/ajprenal.00585.2014 Palmer, 2004, Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system, N Engl J Med, 351, 585, 10.1056/NEJMra035279 St-Jules, 2018, Assessment and misassessment of potassium, phosphorus, and protein in the hemodialysis diet, Semin Dial, 31, 479, 10.1111/sdi.12713 Welch, 2009, Variation in intakes of calcium, phosphorus, magnesium, iron and potassium in 10 countries in the European Prospective Investigation into Cancer and Nutrition study, Eur J Clin Nutr, 63, S101, 10.1038/ejcn.2009.77 Yin, 2018, Association patterns of urinary sodium, potassium, and their ratio with blood pressure across various levels of salt-diet regions in China, Sci Rep, 8, 6727, 10.1038/s41598-018-25097-1 Cogswell, 2012, Sodium and potassium intakes among US adults: NHANES 2003-2008, Am J Clin Nutr, 96, 647, 10.3945/ajcn.112.034413 Tyson, 2012, The Dietary Approaches to Stop Hypertension (DASH) eating pattern in special populations, Curr Hypertens Rep, 14, 388, 10.1007/s11906-012-0296-1 St-Jules, 2016, Nutrient non-equivalence: does restricting high-potassium plant foods help to prevent hyperkalemia in hemodialysis patients?, J Ren Nutr, 26, 282 Sherman, 2009, Phosphorus and potassium content of enhanced meat and poultry products: implications for patients who receive dialysis, Clin J Am Soc Nephrol, 4, 1370, 10.2215/CJN.02830409 Parpia, 2018, The impact of additives on the phosphorus, potassium, and sodium content of commonly consumed meat, poultry, and fish products among patients with chronic kidney disease, J Ren Nutr, 28, 83 Parpia, 2018, Sodium-reduced meat and poultry products contain a significant amount of potassium from food additives, J Acad Nutr Diet, 118, 878, 10.1016/j.jand.2017.10.025 van Buren, 2016, Dietary impact of adding potassium chloride to foods as a sodium reduction technique, Nutrients, 8, 235, 10.3390/nu8040235 Aburto, 2013, Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses, BMJ, 346, f1378, 10.1136/bmj.f1378 Filippini, 2017, The effect of potassium supplementation on blood pressure in hypertensive subjects: a systematic review and meta-analysis, Int J Cardiol, 230, 127, 10.1016/j.ijcard.2016.12.048 Binia, 2015, Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials, J Hypertens, 33, 1509, 10.1097/HJH.0000000000000611 Vinceti, 2016, Meta-analysis of potassium intake and the risk of stroke, J Am Heart Assoc, 5 Seth, 2014, Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative, Stroke, 45, 2874, 10.1161/STROKEAHA.114.006046 Therrien, 2014, Comparison of dietary intake among women on maintenance dialysis to a Women's Health Initiative cohort: results from the NKF-CRN Second National Research Question Collaborative Study, J Ren Nutr, 24, 72 Luis, 2016, Dietary quality and adherence to dietary recommendations in patients undergoing hemodialysis, J Ren Nutr, 26, 190 Noori, 2010, Dietary potassium intake and mortality in long-term hemodialysis patients, Am J Kidney Dis, 56, 338, 10.1053/j.ajkd.2010.03.022 St-Jules, 2016, Exploring problems in following the hemodialysis diet and their relation to energy and nutrient intakes: the BalanceWise Study, J Ren Nutr, 26, 118 Smyth, 2014, The relationship between estimated sodium and potassium excretion and subsequent renal outcomes, Kidney Int, 86, 1205, 10.1038/ki.2014.214 Gritter, 2018, Rationale and design of a randomized placebo-controlled clinical trial assessing the renoprotective effects of potassium supplementation in chronic kidney disease, Nephron, 140, 48, 10.1159/000490261 Rabelink, 1990, Early and late adjustment to potassium loading in humans, Kidney Int, 38, 942, 10.1038/ki.1990.295 Cappuccio, 2016, Systematic review and meta-analysis of randomised controlled trials on the effects of potassium supplements on serum potassium and creatinine, BMJ Open, 6, e011716, 10.1136/bmjopen-2016-011716 Winkler, 1941, The toxicity of orally administered potassium salts in renal insufficiency, J Clin Invest, 20, 119, 10.1172/JCI101204 Keith, 1947, The tolerance for potassium in severe renal insufficiency;a study of 10 cases, J Clin Invest, 26, 773, 10.1172/JCI101860 Allon, 1993, Glucose modulation of the disposal of an acute potassium load in patients with end-stage renal disease, Am J Med, 94, 475, 10.1016/0002-9343(93)90081-Y Sterns, 1979, Disposition of intravenous potassium in anuric man: a kinetic analysis, Kidney Int, 15, 651, 10.1038/ki.1979.85 Blumberg, 1992, Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure, Kidney Int, 41, 369, 10.1038/ki.1992.51 Alvestrand, 1984, Insulin-mediated potassium uptake is normal in uremic and healthy subjects, Am J Physiol, 246, E174 Mathialahan, 2005, Enhanced large intestinal potassium permeability in end-stage renal disease, J Pathol, 206, 46, 10.1002/path.1750 Araki, 2015, Urinary potassium excretion and renal and cardiovascular complications in patients with type 2 diabetes and normal renal function, Clin J Am Soc Nephrol, 10, 2152, 10.2215/CJN.00980115 Eisenga, 2016, Urinary potassium excretion, renal ammoniagenesis, and risk of graft failure and mortality in renal transplant recipients, Am J Clin Nutr, 104, 1703, 10.3945/ajcn.116.134056 He, 2016, Urinary sodium and potassium excretion and CKD progression, J Am Soc Nephrol, 27, 1202, 10.1681/ASN.2015010022 Kieneker, 2016, Low potassium excretion but not high sodium excretion is associated with increased risk of developing chronic kidney disease, Kidney Int, 90, 888, 10.1016/j.kint.2016.07.012 Leonberg-Yoo, 2017, Urine potassium excretion, kidney failure, and mortality in CKD, Am J Kidney Dis, 69, 341, 10.1053/j.ajkd.2016.03.431 Mirmiran, 2018, Dietary sodium to potassium ratio and the incidence of chronic kidney disease in adults: a longitudinal follow-up study, Prev Nutr Food Sci, 23, 87, 10.3746/pnf.2018.23.2.87 Smyth, 2016, Diet and major renal outcomes:a prospective cohort study. The NIH-AARP Diet and Health Study, J Ren Nutr, 26, 288 Kim, 2019, Urinary potassium excretion and progression of CKD, Clin J Am Soc Nephrol, 14, 330, 10.2215/CJN.07820618 Seidelmann, 2018, Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis, Lancet Public Health, 3, e419, 10.1016/S2468-2667(18)30135-X Tharrey, 2018, Patterns of plant and animal protein intake are strongly associated with cardiovascular mortality: the Adventist Health Study-2 cohort, Int J Epidemiol, 47, 1603, 10.1093/ije/dyy030 Song, 2016, Association of animal and plant protein intake with all-cause and cause-specific mortality, JAMA Intern Med, 176, 1453, 10.1001/jamainternmed.2016.4182 Dunkler, 2015, Dietary risk factors for incidence or progression of chronic kidney disease in individuals with type 2 diabetes in the European Union, Nephrol Dial Transplant, 30 Kelly, 2017, Healthy dietary patterns and risk of mortality and ESRD in CKD: A meta-analysis of cohort studies, Clin J Am Soc Nephrol, 12, 272, 10.2215/CJN.06190616 Estruch, 2018, Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts, N Engl J Med, 378, e34, 10.1056/NEJMoa1800389 Chen, 2016, The associations of plant protein intake with all-cause mortality in CKD, Am J Kidney Dis, 67, 423, 10.1053/j.ajkd.2015.10.018 Sotomayor CG, Gomes-Neto AW, Eisenga MF, et al. Consumption of fruits and vegetables and cardiovascular mortality in renal transplant recipients: a prospective cohort study [e-pub ahead of print]. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfy248. Accessed October 8, 2019. Saglimbene, 2019, Fruit and vegetable intake and mortality in adults undergoing mainteinance hemodialysis, Clin J Am Soc Nephrol, 14, 250, 10.2215/CJN.08580718 Arnold, 2017, Randomized, controlled trial of the effect of dietary potassium restriction on nerve function in CKD, Clin J Am Soc Nephrol, 12, 1569, 10.2215/CJN.00670117 Goraya, 2013, A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate, Clin J Am Soc Nephrol, 8, 371, 10.2215/CJN.02430312 Tyson, 2016, Short-term effects of the DASH diet in adults with moderate chronic kidney disease: a pilot feeding study, Clin Kidney J, 9, 592, 10.1093/ckj/sfw046 Hannah, 2018, The feasibility of using the Dietary Approaches to Stop Hypertension (DASH) diet in people with chronic kidney disease and hypertension, J Clin Nephrol Kidney Dis, 3, 1015 Kovesdy, 2018, Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis, Eur Heart J, 39, 1535, 10.1093/eurheartj/ehy100 Luo, 2016, Association between serum potassium and outcomes in patients with reduced kidney function, Clin J Am Soc Nephrol, 11, 90, 10.2215/CJN.01730215 Bowling, 2010, Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies, Circ Heart Fail, 3, 253, 10.1161/CIRCHEARTFAILURE.109.899526 Nakhoul, 2015, Serum potassium, end-stage renal disease and mortality in chronic kidney disease, Am J Nephrol, 41, 456, 10.1159/000437151 Paltiel, 2001, Management of severe hypokalemia in hospitalized patients: a study of quality of care based on computerized databases, Arch Intern Med, 161, 1089, 10.1001/archinte.161.8.1089 Chen, 2016, Serum potassium, mortality, and kidney outcomes in the Atherosclerosis Risk in Communities Study, Mayo Clin Proc, 91, 1403, 10.1016/j.mayocp.2016.05.018 Reumkens, 2017, Prevalence of hypokalemia before and after bowel preparation for colonoscopy in high-risk patients, Gastrointest Endosc, 86, 673, 10.1016/j.gie.2017.01.040 Wahr, 1999, Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Perioperative Ischemia Research Group, JAMA, 281, 2203, 10.1001/jama.281.23.2203 Marti, 2014, Etiology and symptoms of severe hypokalemia in emergency department patients, Eur J Emerg Med, 21, 46 Singer, 2017, A retrospective study of emergency department potassium disturbances: severity, treatment, and outcomes, Clin Exp Emerg Med, 4, 73, 10.15441/ceem.16.194 Crop, 2007, Hypokalaemia and subsequent hyperkalaemia in hospitalized patients, Nephrol Dial Transplant, 22, 3471, 10.1093/ndt/gfm471 Hayes, 2012, Association of hypo- and hyperkalemia with disease progression and mortality in males with chronic kidney disease: the role of race, Nephron Clin Pract, 120, c8, 10.1159/000329511 Lee, 2017, Lower serum potassium associated with increased mortality in dialysis patients: a nationwide prospective observational cohort study in Korea, PLoS One, 12 Torlen, 2012, Serum potassium and cause-specific mortality in a large peritoneal dialysis cohort, Clin J Am Soc Nephrol, 7, 1272, 10.2215/CJN.00960112 Jung, 2009, De novo hypokalemia in incident peritoneal dialysis patients: a 1-year observational study, Electrolyte Blood Press, 7, 73, 10.5049/EBP.2009.7.2.73 Szeto, 2005, Hypokalemia in Chinese peritoneal dialysis patients: prevalence and prognostic implication, Am J Kidney Dis, 46, 128, 10.1053/j.ajkd.2005.03.015 Xu, 2014, Serum potassium levels and its variability in incident peritoneal dialysis patients: associations with mortality, PLoS One, 9 Born-Frontsberg, 2009, Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's Registry, J Clin Endocrinol Metab, 94, 1125, 10.1210/jc.2008-2116 Krogager, 2017, Short-term mortality risk of serum potassium levels in hypertension: a retrospective analysis of nationwide registry data, Eur Heart J, 38, 104 Alderman, 2012, Clinical significance of incident hypokalemia and hyperkalemia in treated hypertensive patients in the antihypertensive and lipid-lowering treatment to prevent heart attack trial, Hypertension, 59, 926, 10.1161/HYPERTENSIONAHA.111.180554 Karaboyas, 2017, Dialysate potassium, serum potassium, mortality, and arrhythmia events in hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS), Am J Kidney Dis, 69, 266, 10.1053/j.ajkd.2016.09.015 Zanger, 2010, Hyponatremia and hypokalemia in patients on peritoneal dialysis, Semin Dial, 23, 575, 10.1111/j.1525-139X.2010.00789.x Mukete, 2013, Effects of low-dose thiazide diuretics on fasting plasma glucose and serum potassium-a meta-analysis, J Am Soc Hypertens, 7, 454, 10.1016/j.jash.2013.05.004 Nilsson, 2017, Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system, Int J Cardiol, 245, 277, 10.1016/j.ijcard.2017.07.035 Roush, 2016, Diuretics for hypertension: a review and update, Am J Hypertens, 29, 1130, 10.1093/ajh/hpw030 Savage, 1998, Arch Intern Med, 158, 741, 10.1001/archinte.158.7.741 Tannen, 1985, Diuretic-induced hypokalemia, Kidney Int, 28, 988, 10.1038/ki.1985.229 Roush, 2015, Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects, Hypertension, 65, 1041, 10.1161/HYPERTENSIONAHA.114.05021 Rodenburg, 2014, Thiazides and the risk of hypokalemia in the general population, J Hypertens, 32, 2092, 10.1097/HJH.0000000000000299 Gennari, 1998, Hypokalemia, N Engl J Med, 339, 451, 10.1056/NEJM199808133390707 Wu, 2017, Identification of the causes for chronic hypokalemia: importance of urinary sodium and chloride excretion, Am J Med, 130, 846, 10.1016/j.amjmed.2017.01.023 Asmar, 2012, A physiologic-based approach to the treatment of a patient with hypokalemia, Am J Kidney Dis, 60, 492, 10.1053/j.ajkd.2012.01.031 Siegel, 1992, Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men, JAMA, 267, 1083, 10.1001/jama.1992.03480080053026 Helfant, 1986, Hypokalemia and arrhythmias, Am J Med, 80, 13, 10.1016/0002-9343(86)90336-0 Kline, 2017, Primary aldosteronism: a common cause of resistant hypertension, CMAJ, 189, E773, 10.1503/cmaj.161486 Funder, 2016, The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab, 101, 1889, 10.1210/jc.2015-4061 Rossi, 2006, A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients, J Am Coll Cardiol, 48, 2293, 10.1016/j.jacc.2006.07.059 Mulatero, 2002, Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism, Hypertension, 40, 897, 10.1161/01.HYP.0000038478.59760.41 Mulatero, 2004, Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents, J Clin Endocrinol Metab, 89, 1045, 10.1210/jc.2003-031337 Lin, 2007, Hypokalemia: a practical approach to diagnosis and its genetic basis, Curr Med Chem, 14, 1551, 10.2174/092986707780831050 Unwin, 2011, Pathophysiology and management of hypokalemia: a clinical perspective, Nat Rev Nephrol, 7, 75, 10.1038/nrneph.2010.175 Lin, 2004, Laboratory tests to determine the cause of hypokalemia and paralysis, Arch Intern Med, 164, 1561, 10.1001/archinte.164.14.1561 Halperin, 2017, Assessing the renal response in patients with potassium disorders: a shift in emphasis from the TTKG to the urine K+/creatinine ratio, Afr J Nephol, 20, 22 Hooft van Huysduynen, 2014, Evaluation of using spot urine to replace 24 h urine sodium and potassium excretions, Public Health Nutr, 17, 2505, 10.1017/S1368980014001177 Polonia, 2017, Estimation of populational 24-h urinary sodium and potassium excretion from spot urine samples: evaluation of four formulas in a large national representative population, J Hypertens, 35, 477, 10.1097/HJH.0000000000001180 Musso, 2006, Transtubular potassium concentration gradient:comparison between healthy old people and chronic renal failure patients, Int Urol Nephrol, 38, 387, 10.1007/s11255-006-0059-5 Kamel, 2011, Intrarenal urea recycling leads to a higher rate of renal excretion of potassium: an hypothesis with clinical implications, Curr Opin Nephrol Hypertens, 20, 547, 10.1097/MNH.0b013e328349b8f9 Kruse, 1990, Rapid correction of hypokalemia using concentrated intravenous potassium chloride infusions, Arch Intern Med, 150, 613, 10.1001/archinte.1990.00390150101019 Cohn, 2000, New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice, Arch Intern Med, 160, 2429, 10.1001/archinte.160.16.2429 Kruse, 1994, Concentrated potassium chloride infusions in critically ill patients with hypokalemia, J Clin Pharmacol, 34, 1077, 10.1002/j.1552-4604.1994.tb01984.x Pham, 2000, Overcorrection of hyponatremia: where do we go wrong?, Am J Kidney Dis, 36, E12, 10.1053/ajkd.2000.9013 Griffing, 1983, Reversal of diuretic-induced secondary hyperaldosteronism and hypokalemia by enalapril (MK-421): a new angiotensin-converting enzyme inhibitor, Metabolism, 32, 711, 10.1016/0026-0495(83)90129-4 Maronde, 1983, Response of thiazide-induced hypokalemia to amiloride, JAMA, 249, 237, 10.1001/jama.1983.03330260055032 Schnaper, 1989, Potassium restoration in hypertensive patients made hypokalemic by hydrochlorothiazide, Arch Intern Med, 149, 2677, 10.1001/archinte.1989.00390120043009 Gradman, 2010, Combination therapy in hypertension, J Am Soc Hypertens, 4, 42, 10.1016/j.jash.2010.02.005 Kohvakka, 1988, Maintenance of potassium balance during long-term diuretic therapy in chronic heart failure patients with thiazide-induced hypokalemia: comparison of potassium supplementation with potassium chloride and potassium-sparing agents, amiloride and triamterene, Int J Clin Pharmacol Ther Toxicol, 26, 273 Jackson, 1982, Relative potency of spironolactone, triamterene and potassium chloride in thiazide-induced hypokalaemia, Br J Clin Pharmacol, 14, 257, 10.1111/j.1365-2125.1982.tb01970.x Robinson, 2017, Magnesium lactate in the treatment of Gitelman syndrome: patient-reported outcomes, Nephrol Dial Transplant, 32, 508 Whang, 1992, Refractory potassium repletion. A consequence of magnesium deficiency, Arch Intern Med, 152, 40, 10.1001/archinte.1992.00400130066006 Blanchard, 2015, Indomethacin, amiloride, or eplerenone for treating hypokalemia in Gitelman syndrome, J Am Soc Nephrol, 26, 468, 10.1681/ASN.2014030293 Ito, 2014, Long-term effects of spironolactone in peritoneal dialysis patients, J Am Soc Nephrol, 25, 1094, 10.1681/ASN.2013030273 Langote, 2017, Spironolactone is effective in treating hypokalemia among peritoneal dialysis patients, PLoS One, 12, 10.1371/journal.pone.0187269 Ribeiro, 2017, Impact of renin-angiotensin aldosterone system inhibition on serum potassium levels among peritoneal dialysis patients, Am J Nephrol, 46, 150, 10.1159/000479011 Yu, 2014, Potassium metabolism in continuous ambulatory peritoneal dialysis patients, Ren Fail, 36, 748, 10.3109/0886022X.2014.884379 Pfortmuller, 2013, Hyperkalemia in the emergency department: etiology, symptoms and outcome of a life threatening electrolyte disorder, Eur J Intern Med, 24, e59, 10.1016/j.ejim.2013.02.010 Bandak, 2017, Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) Project, J Am Heart Assoc, 6 Gasparini, 2019, Plasma potassium ranges associated with mortality across stages of chronic kidney disease: the Stockholm CREAtinine Measurements (SCREAM) project, Nephrol Dial Transplant, 34, 1534, 10.1093/ndt/gfy249 Trevisan, 2018, Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists, Eur J Heart Fail, 20, 1217, 10.1002/ejhf.1199 Xu, 2018, Dyskalemias and adverse events associated with discharge potassium in acute myocardial infarction, Am Heart J, 205, 53, 10.1016/j.ahj.2018.06.009 Cooper, 2019, Clinical and research implications of serum versus plasma potassium measurements, Eur J Heart Fail, 21, 536, 10.1002/ejhf.1371 Hartland, 1999, Serum potassium is unreliable as an estimate of in vivo plasma potassium, Clin Chem, 45, 1091, 10.1093/clinchem/45.7.1091 Luukkonen, 2016, Evaluation of a hand-held blood gas analyzer for rapid determination of blood gases, electrolytes and metabolites in intensive care setting, Clin Chem Lab Med, 54, 585, 10.1515/cclm-2015-0592 Gavala, 2017, Comparison of point-of-care versus central laboratory measurement of hematocrit, hemoglobin, and electrolyte concentrations, Heart Lung, 46, 246, 10.1016/j.hrtlng.2017.04.003 Allardet-Servent, 2017, Point-of-care versus central laboratory measurements of hemoglobin, hematocrit, glucose, bicarbonate and electrolytes: a prospective observational study in critically ill patients, PLoS One, 12, 10.1371/journal.pone.0169593 Friedman, 2018, Errors of classification with potassium blood testing: the variability and repeatability of critical clinical tests, Mayo Clin Proc, 93, 566, 10.1016/j.mayocp.2018.03.013 Bloom, 2014, A comparison of measurements of sodium, potassium, haemoglobin and creatinine between an emergency department-based point-of-care machine and the hospital laboratory, Eur J Emerg Med, 21, 310, 10.1097/MEJ.0000000000000076 Dashevsky, 2017, Agreement between serum assays performed in ED point-of-care and hospital central laboratories, West J Emerg Med, 18, 403, 10.5811/westjem.2017.1.30532 Alhaj Moustafa, 2017, A challenging case of pseudohyperkalemia in chronic lymphocytic leukemia, J Investig Med High Impact Case Rep, 5 Salek, 2018, Pseudohyperkalemia - potassium released from cells due to clotting and centrifugation - a case report, Biochem Med (Zagreb), 28, 10.11613/BM.2018.011002 Seimiya, 2010, Reducing the incidence of pseudohyperkalemia by avoiding making a fist during phlebotomy: a quality improvement report, Am J Kidney Dis, 56, 686, 10.1053/j.ajkd.2010.06.014 Mattu, 2000, Electrocardiographic manifestations of hyperkalemia, Am J Emerg Med, 18, 721, 10.1053/ajem.2000.7344 Campese, 2016, Electrophysiological and clinical consequences of hyperkalemia, Kidney Int Suppl, 6, 16, 10.1016/j.kisu.2016.01.003 Dendramis, 2017, Not all ST-segment elevations are myocardial infarction: hyperkalemia and Brugada phenocopy, Am J Emerg Med, 35, 662.e1, 10.1016/j.ajem.2016.10.063 Littmann, 2018, Electrocardiographic manifestations of severe hyperkalemia, J Electrocardiol, 51, 814, 10.1016/j.jelectrocard.2018.06.018 Pastor, 2001, Patterns of acute inferior wall myocardial infarction caused by hyperkalemia, J Electrocardiol, 34, 53, 10.1054/jelc.2001.22062 Peerbhai, 2017, Hyperkalemia masked by pseudo-stemi infarct pattern and cardiac arrest, Int J Emerg Med, 10, 3, 10.1186/s12245-017-0132-0 Montague, 2008, Retrospective review of the frequency of ECG changes in hyperkalemia, Clin J Am Soc Nephrol, 3, 324, 10.2215/CJN.04611007 Durfey, 2017, Severe hyperkalemia: can the electrocardiogram risk stratify for short-term adverse events?, West J Emerg Med, 18, 963, 10.5811/westjem.2017.6.33033 Ryuge, 2017, Warning: the ECG may be normal in severe hyperkalemia, Intern Med, 56, 2243, 10.2169/internalmedicine.6895-15 Elliott, 2010, Management of patients with acute hyperkalemia, CMAJ, 182, 1631, 10.1503/cmaj.100461 Kessler, 2011, The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia, J Hosp Med, 6, 136, 10.1002/jhm.834 Truhlář, 2015, European Resuscitation Council Guidelines for Resuscitation 2015: Section 4. Cardiac arrest in special circumstances, Resuscitation, 95, 148, 10.1016/j.resuscitation.2015.07.017 Lin, 2007, Skin necrosis after intravenous calcium chloride administration as a complication of parathyroidectomy for secondary hyperparathyroidism: report of four cases, Surg Today, 37, 778, 10.1007/s00595-006-3426-z Batterink, 2015, Pharmacological interventions for the acute management of hyperkalaemia in adults, Cochrane Database Syst Rev, 10, CD010344 McNicholas, 2018, Treatment of hyperkalemia with a low-dose insulin protocol is effective and results in reduced hypoglycemia, Kidney Int Rep, 3, 328, 10.1016/j.ekir.2017.10.009 Alfonzo, 2014 Mahoney, 2005, Emergency interventions for hyperkalaemia, Cochrane Database Syst Rev, 2, CD003235 Kaplan, 1997, Alkalinization is ineffective for severe hyperkalemia in nonnephrectomized dogs. Hyperkalemia Research Group, Acad Emerg Med, 4, 93, 10.1111/j.1553-2712.1997.tb03713.x Kim, 1997, Acute therapy for hyperkalemia with the combined regimen of bicarbonate and beta(2)-adrenergic agonist (salbutamol) in chronic renal failure patients, J Korean Med Sci, 12, 111, 10.3346/jkms.1997.12.2.111 Coggon, 2003, Quantifying disease in populations, 6 Lazich, 2014, Prediction and management of hyperkalemia across the spectrum of chronic kidney disease, Semin Nephrol, 34, 333, 10.1016/j.semnephrol.2014.04.008 Collins, 2017, Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes, Am J Nephrol, 46, 213, 10.1159/000479802 Garlo, 2018, Association of changes in creatinine and potassium levels after initiation of renin angiotensin aldosterone system inhibitors with emergency department visits, hospitalizations, and mortality in individuals with chronic kidney disease, JAMA Netw Open, 1, 10.1001/jamanetworkopen.2018.3874 Furuland, 2018, Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink, BMC Nephrol, 19, 211, 10.1186/s12882-018-1007-1 Johnson, 2010, Predicting the risk of hyperkalemia in patients with chronic kidney disease starting lisinopril, Pharmacoepidemiol Drug Saf, 19, 266, 10.1002/pds.1923 Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol, 62, e147, 10.1016/j.jacc.2013.05.019 Nilsson, 2018, A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure, Eur Heart J Qual Care Clin Outcomes, 4, 267, 10.1093/ehjqcco/qcy019 Arora, 2017, Preoperative serum potassium predicts the clinical outcome after non-cardiac surgery, Clin Chem Lab Med, 55, 145, 10.1515/cclm-2016-0038 Medcalf, 2001, Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis, Kidney Int, 59, 1128, 10.1046/j.1523-1755.2001.0590031128.x Dargie, 1972, High dosage metolazone in chronic renal failure, Br Med J, 4, 196, 10.1136/bmj.4.5834.196 Reubi, 1961, Effects of reduced glomerular filtration rate on responsiveness to chlorothiazide and mercurial diuretics, Circulation, 23, 200, 10.1161/01.CIR.23.2.200 Allison, 1971, Diuretics in chronic renal disease: a study of high dosage frusemide, Clin Sci, 41, 171, 10.1042/cs0410171 Kaisar, 2006, A randomized controlled trial of fludrocortisone for the treatment of hyperkalemia in hemodialysis patients, Am J Kidney Dis, 47, 809, 10.1053/j.ajkd.2006.01.014 Dick, 2011, Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients, Transplant Proc, 43, 2664, 10.1016/j.transproceed.2011.07.006 Mathialahan, 2003, Dietary potassium and laxatives as regulators of colonic potassium secretion in end-stage renal disease, Nephrol Dial Transplant, 18, 341, 10.1093/ndt/18.2.341 Sterns, 2010, Ion-exchange resins for the treatment of hyperkalemia: are they safe and effective?, J Am Soc Nephrol, 21, 733, 10.1681/ASN.2010010079 US Food and Drug Administration 2018, Framework for assessing pH-dependent drug-drug interactions, Fed Regist, 83, 23688 Pitt, 2015, New potassium binders for the treatment of hyperkalemia: current data and opportunities for the future, Hypertension, 66, 731, 10.1161/HYPERTENSIONAHA.115.04889 Beccari, 2017, Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review, Core Evid, 12, 11, 10.2147/CE.S129555 Fishbane, 2019, A phase 3b, randomized, double-blind, placebo-controlled study of sodium zirconium cyclosilicate for reducing the incidence of predialysis hyperkalemia, J Am Soc Nephrol, 30, 1723—1733, 10.1681/ASN.2019050450 Lepage, 2015, Randomized clinical trial of sodium polystyrene sulfonate for the treatment of mild hyperkalemia in CKD, Clin J Am Soc Nephrol, 10, 2136, 10.2215/CJN.03640415 Kovesdy, 2019, Real-world evaluation of patiromer for the treatment of hyperkalemia in hemodialysis patients, Kidney Int Rep, 4, 301, 10.1016/j.ekir.2018.10.020 Hunt, 2019, Single-dose sodium polystyrene sulfonate for hyperkalemia in chronic kidney disease or end-stage renal disease, Clin Kidney J, 12, 408, 10.1093/ckj/sfy063 Georgianos, 2018, Revisiting RAAS blockade in CKD with newer potassium-binding drugs, Kidney Int, 93, 325, 10.1016/j.kint.2017.08.038 Watson, 2012, Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study, Am J Kidney Dis, 60, 409, 10.1053/j.ajkd.2012.04.023 Noel JA, Bota SE, Petrcich W, et al. Risk of hospitalizations for serious adverse gastrointestinal events associated with sodium polystyrene sulfonate use in patients with advanced age [e-pub ahead of print]. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2019.0631. Accessed October 9, 2019. Laureati P, Xu Y, Trevisan M, et al. Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study [e-pub ahead of print]. Nephrol Dial Transplant. https://doi.org/10.1093/ndt/gfz150. Accessed October 9, 2019. Parks, 2019, Sodium polystyrene sulfonate for hyperkalemia, JAMA Intern Med, 179, 1023, 10.1001/jamainternmed.2019.1291 Savarese, 2019, The Swedish Heart Failure Registry: a living, ongoing quality assurance and research in heart failure, Ups J Med Sci, 124, 65, 10.1080/03009734.2018.1490831 Jun, 2019, Hyperkalemia and renin-angiotensin aldosterone system inhibitor therapy in chronic kidney disease: a general practice-based, observational study, PLoS One, 14, 10.1371/journal.pone.0213192 Weir, 2015, Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors, N Engl J Med, 372, 211, 10.1056/NEJMoa1410853 Spinowitz, 2019, Sodium zirconium cyclosilicate among individuals with hyperkalemia: a 12-month phase 3 study, Clin J Am Soc Nephrol, 14, 798, 10.2215/CJN.12651018 Agarwal, 2019, Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial, Lancet, 394, 1540, 10.1016/S0140-6736(19)32135-X Brenner, 2001, Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N Engl J Med, 345, 861, 10.1056/NEJMoa011161 Hou, 2006, Efficacy and safety of benazepril for advanced chronic renal insufficiency, N Engl J Med, 354, 131, 10.1056/NEJMoa053107 Bhandari, 2016, Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial, Nephrol Dial Transplant, 31, 255 Ferrey, 2018, Dialysate potassium and mortality in a prospective hemodialysis cohort, Am J Nephrol, 47, 415, 10.1159/000489961 Brunelli, 2018, Serum-to-dialysate potassium gradient and its association with short-term outcomes in hemodialysis patients, Nephrol Dial Transplant, 33, 1207, 10.1093/ndt/gfx241 Ohnishi, 2019, Postdialysis hypokalemia and all-cause mortality in patients undergoing maintenance hemodialysis, Clin J Am Soc Nephrol, 14, 873, 10.2215/CJN.07950718